- Research works
- 54 ▲ 6% vs 2013–17
- Citations
- 3k 56.6 per fractional work
- Top-10% rate
- 47.9% record average 16.5%
- Open access
- 68% world 28%
Not ranked overall: Adimab (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 12.3×. Every wedge is a field page.
Who are the top researchers at Adimab (United States)?
Ranked on the composite score, Tushar Jain lead among researchers whose main affiliation is Adimab (United States).
- 1 Tushar Jain United States · #938,382 worldwide 77 citations · 16 works
Which keywords describe research at Adimab (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Antibody Engineering, Fc Receptors, Biopharmaceuticals, Immunogenicity and Recombinant Proteins.
- Vaccine Development
- spike protein
- Biosimilars
- Clinical Outcomes
- Glycans
- Coronavirus
- Immune Response
- Immunity
- Epitope Prediction
- Recombinant Protein
- Antigen Presentation
- Vaccine
- Epidemiology
- Immunotherapy
- CAR T Cells
- Protein Aggregation
- Recombinant Proteins
- Biopharmaceuticals
- Antibody Engineering
- Therapeutic Antibodies
- Monoclonal Antibodies
- Glycosylation
- Fc Receptors
- Immunogenicity
- Cancer Immunotherapy
- Stability
- Chimeric Antigen Receptor
- Tumor Regression
- Monoclonal Antibody
- Pathogenesis
- Mammalian Cells
- Cancer
- Peptide-MHC Binding
- Pandemic
- ACE2 Receptor
- SARS-CoV-2
- Immune System
- Bioanalytical Methods
- antibody
- Health Care Utilization
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Monoclonal Antibodies18▲ 237×3 topics
- Therapeutic Antibodies17▲ 246×2 topics
- Glycosylation15▲ 127×3 topics
- Antibody Engineering11▲ 208×1 topic
- Fc Receptors11▲ 208×1 topic
- Biopharmaceuticals8▲ 211×3 topics
- Immunogenicity7▲ 257×2 topics
- Recombinant Proteins6▲ 226×2 topics
- Cancer Immunotherapy6▲ 80×3 topics
- Protein Aggregation6▲ 137×1 topic
- Stability6▲ 56×1 topic
- CAR T Cells5▲ 221×1 topic
- Chimeric Antigen Receptor5▲ 221×1 topic
- Immunotherapy5▲ 15×2 topics
- Tumor Regression5▲ 112×2 topics
- Epidemiology5▲ 2.3×16 topics
- Monoclonal Antibody3▲ 82×2 topics
- Vaccine3▲ 14×5 topics
- Pathogenesis3▲ 9.7×6 topics
- Antigen Presentation3▲ 53×2 topics
- Mammalian Cells2▲ 107×1 topic
- Recombinant Protein2▲ 107×1 topic
- Cancer2▲ 3.0×4 topics
- Epitope Prediction2▲ 209×1 topic
- Peptide-MHC Binding2▲ 209×1 topic
- Immunity2▲ 11×3 topics
- Pandemic2▲ 8.2×3 topics
- Immune Response2▲ 5.8×6 topics
- ACE2 Receptor2▲ 28×2 topics
- Coronavirus2▲ 28×2 topics
- SARS-CoV-22▲ 22×2 topics
- Glycans2▲ 37×1 topic
- Immune System2▲ 9.2×1 topic
- Clinical Outcomes1▲ 13×2 topics
- Bioanalytical Methods1▲ 158×1 topic
- Biosimilars1▲ 158×1 topic
- antibody1▲ 52×1 topic
- spike protein1▲ 52×1 topic
- Health Care Utilization1▲ 15×2 topics
- Vaccine Development1▲ 6.8×3 topics
Which research topics does Adimab (United States) publish most on?
By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, vaccines and immunoinformatics approaches and Protein purification and stability.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 4 works
- 2 CAR-T cell therapy research Oncology 3 works
- 3 vaccines and immunoinformatics approaches Molecular Biology 1 works
- 4 Protein purification and stability Molecular Biology 1 works
- 5 Glycosylation and Glycoproteins Research Molecular Biology 1 works
- 6 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
- 7 COVID-19 Clinical Research Studies Infectious Diseases 0 works
- 8 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
- 9 Galectins and Cancer Biology Immunology 0 works
- 10 Biosimilars and Bioanalytical Methods Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Adimab (United States)'s research output changed?
Output in 2018–2022 was 6% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Lebanon
- Dartmouth–Hitchcock Medical Center
- Dartmouth Psychiatric Research Center
- Dartmouth Institute for Health Policy and Clinical Practice
- Children's Hospital at Dartmouth Hitchcock
- Simbex (United States)
- Woomera Therapeutics
- DoseOptics (United States)
- Upper Valley Educators Institute
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.